Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of 3-fluorin-5-(trifluoromethyl)-N-(2-(1-piperidyl) ethyl) benzamide hydrochloride in the preparation of medicine and feed for resisting H5N1 type avian influenza virus

A bird flu virus, trifluoromethyl technology, applied in the field of pharmaceuticals, can solve the problems of low antiviral activity and unclear site of action

Inactive Publication Date: 2011-05-25
SOUTHERN MEDICAL UNIVERSITY
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the antiviral activity of Stachyflin is not high, and the site of action is not clear

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of 3-fluorin-5-(trifluoromethyl)-N-(2-(1-piperidyl) ethyl) benzamide hydrochloride in the preparation of medicine and feed for resisting H5N1 type avian influenza virus
  • Application of 3-fluorin-5-(trifluoromethyl)-N-(2-(1-piperidyl) ethyl) benzamide hydrochloride in the preparation of medicine and feed for resisting H5N1 type avian influenza virus
  • Application of 3-fluorin-5-(trifluoromethyl)-N-(2-(1-piperidyl) ethyl) benzamide hydrochloride in the preparation of medicine and feed for resisting H5N1 type avian influenza virus

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0086] Weigh 50 g of 3-fluoro-5-(trifluoromethyl)-N-(2-(1-piperidinyl)ethyl)benzamide hydrochloride, 96 g of starch, and 50 g of dextrin and mix well. In addition, dissolve 2g of tartaric acid in 50% ethanol, add an appropriate amount to the mixed powder at one time to make a soft material, pass through a 18-20 mesh nylon sieve to make wet granules, dry below 60°C, granulate, and sieve 2g Magnesium stearate is mixed, compressed into tablets (0.2g per tablet), and each tablet contains 50mg of the compound, quality inspection, packaging, to obtain the tablet of the compound. It is suitable for healthy people and those infected with H5N1 influenza at the initial stage, 3 times a day, 3 tablets each time.

Embodiment 2

[0088] Weigh 50 g of 3-fluoro-5-(trifluoromethyl)-N-(2-(1-piperidinyl)ethyl)benzamide hydrochloride, 96 g of starch, and 50 g of dextrin and mix well. In addition, 2g of tartaric acid was dissolved in 50% ethanol, and an appropriate amount was added to the mixed powder at one time to make a soft material, which was made into wet granules through a 18-20 mesh nylon sieve, dried below 60°C, granulated, and sieved 2g Magnesium stearate is mixed, and encapsulated (0.2g per capsule), each capsule contains 50mg of the compound, and the quality inspection gives the capsule of the compound. It is suitable for healthy people and those infected with H5N1 influenza at the initial stage, 3 times a day, 3 capsules each time.

Embodiment 3

[0090] Weigh 5 g of 3-fluoro-5-(trifluoromethyl)-N-(2-(1-piperidinyl)ethyl)benzamide hydrochloride and 9 g of sodium chloride. Add water to make 1000ml, the concentration is 0.5%, sterilize with hot-pressed steam at 120°C for 20-30min, and make nasal drops according to the conventional method, 20ml / support. It is suitable for healthy people and those infected with H5N1 influenza at the initial stage. Nasal drip once an hour, 1-2 drops in each nostril each time.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
melting pointaaaaaaaaaa
Login to View More

Abstract

The invention discloses application of 3-fluorin-5-(trifluoromethyl)-N-(2-(1-piperidyl) ethyl) benzamide hydrochloride in the preparation of medicine and feed for resisting H5N1 type avian influenza virus. The compound has high antiviral activity, accurate acting point, breaks ectypal link in the early stage of the virus infection, reduces blood plasma virus carrying capability, has obvious advantage; the medicine for resisting H5N1 type avian influenza virus prepared by the compound can inhibit the infection of the H5N1 type avian influenza virus, reduces gene mutation rate of H5N1 type avian influenza virus and provides new medicine combination for treating and preventing the H5N1 type avian influenza virus.

Description

technical field [0001] The present invention relates to the use of 3-fluoro-5-(trifluoromethyl)-N-(2-(1-piperidinyl)ethyl)benzamide hydrochloride, in particular to the use in the pharmaceutical field. Background technique [0002] Influenza is an acute respiratory infectious disease caused by influenza virus. Influenza virus is an enveloped virus, and its entry into target cells requires the mediation of membrane glycoproteins. The envelope protein of influenza virus that mediates membrane fusion is hemagglutinin (HA). HA consists of two subunits, HA1 and HA2. Among them, HA1 has 328 amino acid residues, and HA2 has 221 amino acid residues. HA1 first binds to the sialic acid receptor on the target cell membrane, and then the virus is pinocytized into the cytoplasm and wrapped in the endosome; HA2 is a transmembrane subunit that mediates the viral membrane and the endosome membrane fusion. In the low pH environment inside the endosome, the conformation of HA2 changes to ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/4453A61P31/16A23K1/16A23K1/18A23K10/22A23K10/30A23K10/37A23K20/10A23K20/142A23K20/174A23K20/26A23K50/70
CPCY02P60/87
Inventor 刘叔文张瑞涛习保民郑伯建
Owner SOUTHERN MEDICAL UNIVERSITY